These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 17348444)
1. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444 [TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer. Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544 [TBL] [Abstract][Full Text] [Related]
3. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell]. Wang Y; Zhou Q; Zhang S; Yang H; Cheng N; Li L; Wu Z; Liu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):178-82. PubMed ID: 11402444 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic role of JC virus in lung cancer. Zheng H; Abdel Aziz HO; Nakanishi Y; Masuda S; Saito H; Tsuneyama K; Takano Y J Pathol; 2007 Jul; 212(3):306-15. PubMed ID: 17534844 [TBL] [Abstract][Full Text] [Related]
5. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785 [TBL] [Abstract][Full Text] [Related]
7. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
8. FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095 [TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer]. Liao DW; Wang L; Zhang XG; Liu MQ Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767 [TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Tomizawa Y; Nakajima T; Kohno T; Saito R; Yamaguchi N; Yokota J Cancer Res; 1998 Dec; 58(23):5478-83. PubMed ID: 9850082 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer]. Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402 [TBL] [Abstract][Full Text] [Related]
14. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
16. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370 [TBL] [Abstract][Full Text] [Related]
18. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865 [TBL] [Abstract][Full Text] [Related]
19. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between the expression of fragile histidine (FHIT) and the development of vulvar carcinoma]. Chu YX; Zheng A; Xi MR; Zhang J Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):218-20. PubMed ID: 16608079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]